We are delighted to announce the appointment of three new members to our advisory board, who join us as we expand our business and product offering.
Nick Walls, Lee Harrison, and Raymond Sze bring a wealth of experience to Ecoinomy in the fields of SaaS technologies, cryptocurrencies, and brand, operations, and business marketing. The appointments are part of a strategic recruitment program that will enable Ecoinomy to expand its services and continue the development of our innovative seed-to-sale blockchain technology that will facilitate affordable access to organic medicines.
|
NICK WALLS
Nick Walls is ex-CEO and founder of r2cOnline, a leading global provider of cloud-based software to the commercial fleet sector, which he exited in 2019 to Fleetcor Inc, a Fortune 250 company. Nick is an experienced SaaS investor, often also acting as a mentor and Board Advisor to early-stage companies.
RAYMOND SZE
Raymond Sze is a seasoned online gaming and marketing executive with extensive experience in the Asian, European, and African markets, for companies such as Bitcoin.com and 138.com. He cofounded KamPay—a digital platform for Africa with bases in Nigeria and Cameroon whose goal it is to help promote financial inclusion throughout the continent.
Lee Harrison is the CEO and founder of Spark Emotions, a global consumer psychology agency, and ex-Brand/Marketing Director at Tescos. He has over 20 years of experience in business strategy, operation, and marketing strategy through to execution specialising in retail, FMCG, and media.
Steve McGeough Joins Ecoinomy as Head of Transformation
We are happy to announce that Steve McGeough has joined the Ecoinomy team to lead us through an integral stage of transformation.
Steve has extensive experience and a successful track record as a Business Leader & Transformation Director with leading FTSE businesses and global FMCG brands, with the last 10 years at executive committee level. At Tesco Mobile Steve was accountable for annual sales of £bn+, operating budgets of £multi-million+, 500 stores, and 2500 colleagues. Steve has a strong commercial focus with in-depth understanding of business drivers and data-led customer insights, and can effectively identify transformational opportunities and champion new digital and technology solutions to deliver seamlessly world-class brand experiences.
In his most recent role, he led the successful Direct To Consumer (DTC) transformation at Vuse; British American Tobacco’s vaping business creating a digital first omnichannel shopping experience.
In addition, Steve is Vice Chair for Honeycroft a charity that specialises in providing affordable child care.
We are delighted to welcome Steve to the Ecoinomy team as we continue to transform and grow. Steve comes with a wealth of experience, and a proven track record in business performance, and will be instrumental in taking our company forward. We look forward to working with him
We are delighted to welcome Steve to the Ecoinomy team as we continue to transform and grow. Steve comes with a wealth of experience, and a proven track record in business performance, and will be instrumental in taking our company forward. We look forward to working with him
We think you might also like this posts:
Earth Day 2023: Why Saving the Planet Is Good For Our Health
At Ecoinomy, we believe that good health is a global fundamental right and that every human being deserves access to affordable, accessible healthcare. As we approach Earth Day 2023, we’re showcasing how good human health and planetary health are intrinsically
Dr Tod Mikuriya’s list
Dr. Tod Mikuriya was a pioneering psychiatrist who spent his career researching and advocating for the medical use of cannabis. Through his work, Dr. Mikuriya treated over 9,000 patients with cannabis and maintained a list of more than 200 ailments
Tips on Overcoming MHRA License Barriers for the UK Medical Cannabis Market
An MHRA license is required to manufacture Cannabis-based products for medicinal use (CBPMs) and active pharmaceutical ingredients (API). This license requires an inspection of the site to confirm it has an appropriate facility, staff and Pharmaceutical Quality Management System and has carried out the required activities (including process and analytical validation). There currently isn’t a way to operate both authorisation processes independently because each regulatory authorisation process requires some aspects of the other. Which presents a problem for new companies looking to enter the market. … Read More